MOUNJARO MULTIDOSE 4,17 MG/ML SOL INJ SC CT CAR VD TRANS X 2,4 ML + CAN APLIC
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1126002080015 -
GGREM
507626060028107 -
Código de barras
7896382709432
O que a fonte publica
- Detentor do registro
- ELI LILLY DO BRASIL LTDA
- Princípios ativos
- TIRZEPATIDA
- Embalagem
- 4,17 MG/ML SOL INJ SC CT CAR VD TRANS X 2,4 ML + CAN APLIC
- Regime de dispensação
- Tarja Vermelha sob restrição
- Tipo de produto
- Novo
- Classe terapêutica
- A10S - ANTIDIABÉTICOS AGONISTAS DE GLP-1
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
- MOUNJARO MULTIDOSE 4,17 MG/ML SOL INJ SC CT CAR VD TRANS X 2,4 ML + CAN APLIC
- MOUNJARO MULTIDOSE
- TIRZEPATIDA
Dados completos da fonte
{
"name": "MOUNJARO MULTIDOSE 4,17 MG/ML SOL INJ SC CT CAR VD TRANS X 2,4 ML + CAN APLIC",
"holder": "ELI LILLY DO BRASIL LTDA",
"stripe": "Tarja Vermelha sob restrição",
"barcodes": [
"7896382709432"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "507626060028107",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "43.940.618/0001-44",
"priceRegime": "Regulado",
"productName": "MOUNJARO MULTIDOSE",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "4,17 MG/ML SOL INJ SC CT CAR VD TRANS X 2,4 ML + CAN APLIC",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha sob restrição",
"factoryPrices": {
"icms-0": "1028.02",
"icms-12": "1168.20",
"icms-17": "1238.58",
"icms-18": "1253.68",
"icms-19": "1269.16",
"icms-20": "1285.03",
"icms-21": "1301.29",
"icms-22": "1317.97",
"icms-23": "1335.09",
"icms-17.5": "1246.08",
"icms-19.5": "1277.04",
"icms-20.5": "1293.11",
"icms-22.5": "1326.48",
"icms-12-alc": "1043.04",
"icms-17-alc": "1105.87",
"icms-18-alc": "1119.36",
"icms-19-alc": "1133.18",
"icms-20-alc": "1147.34",
"icms-21-alc": "1161.87",
"icms-22-alc": "1176.76",
"icms-23-alc": "1192.04",
"withoutTaxes": "917.87",
"icms-17.5-alc": "1112.58",
"icms-19.5-alc": "1140.22",
"icms-20.5-alc": "1154.56",
"icms-22.5-alc": "1184.35"
},
"pisCofinsList": "Negativa",
"substanceText": "TIRZEPATIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "1379.05",
"icms-12": "1567.10",
"icms-17": "1661.51",
"icms-18": "1681.77",
"icms-19": "1702.53",
"icms-20": "1723.82",
"icms-21": "1745.63",
"icms-22": "1768.01",
"icms-23": "1790.98",
"icms-17.5": "1671.57",
"icms-19.5": "1713.10",
"icms-20.5": "1734.66",
"icms-22.5": "1779.43",
"icms-12-alc": "1441.94",
"icms-17-alc": "1528.80",
"icms-18-alc": "1547.45",
"icms-19-alc": "1566.55",
"icms-20-alc": "1586.13",
"icms-21-alc": "1606.22",
"icms-22-alc": "1626.80",
"icms-23-alc": "1647.93",
"withoutTaxes": "1268.91",
"icms-17.5-alc": "1538.08",
"icms-19.5-alc": "1576.29",
"icms-20.5-alc": "1596.11",
"icms-22.5-alc": "1637.29"
},
"invalidBarcodes": [],
"activeSubstances": [
"TIRZEPATIDA"
],
"therapeuticClass": "A10S - ANTIDIABÉTICOS AGONISTAS DE GLP-1",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1126002080015",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10S",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:507626060028107"